No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia

[1]  K. Blennow,et al.  Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[2]  H. Arai,et al.  Disturbed consciousness and asthma , 1997, The Lancet.

[3]  C. Loeb,et al.  Vascular dementia: still a debatable entity? , 1996, Journal of the Neurological Sciences.

[4]  K. Blennow,et al.  A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[5]  J. Trojanowski,et al.  Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease , 1995, Annals of neurology.

[6]  Hiromitsu Iwamoto,et al.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population , 1995, Neurology.

[7]  K. Blennow,et al.  Ubiquitin in Cerebrospinal Fluid in Alzheimer's Disease and Vascular Dementia , 1994, International Psychogeriatrics.

[8]  Jan Six,et al.  Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay , 1993 .

[9]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[10]  K. Blennow,et al.  Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia , 1992, Acta neurologica Scandinavica.

[11]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.